M
MBX
MBX Biosciences Inc
31.88
+0.13+0.41%After Hours: 32.51 +0.63 +1.98%17:29 05/27 EDT
OPEN/PREV CLOSE31.81/31.75
TODAY RANGE31.24-33.06
VOL511.01K
MARKET CAP1.52B
52 WEEK RANGE9.43-45.85
AVG VOL (3M)570.49K
% TURNOVER1.07%
TURNOVER--
P/E (TTM)-14.4378
% RANGE5.72%
EPS(TTM)-2.2081
P/E(FORWARD)-11.5090
P/B3.464
BVPS9.20
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.15B
SHARES OUTSTANDING47.60M
NEXT EARNINGS08/05-08/10
FREE FLOAT36.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/17 20:25
MBX Biosciences (MBX) Is Down 20.8% After Wider Loss, Obesity Data And New CCO - Has The Bull Case Changed?
TipRanks·05/16 14:36
LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)
Simply Wall St·05/14 09:42
MBX Biosciences Advances Obesity And PBH Pipeline As Shares Surge
TipRanks·05/12 16:23
MBX Biosciences price target raised to $56 from $50 at Stifel
Dow Jones·05/12 14:00
MBX Biosciences Is Maintained at Overweight by Barclays
Benzinga·05/12 13:51
Barclays Maintains Overweight on MBX Biosciences, Raises Price Target to $70
Dow Jones·05/12 12:46
MBX Biosciences Is Maintained at Market Outperform by Citizens
TipRanks·05/12 12:11
MBX Biosciences, Inc. (MBX) Receives a Buy from Oppenheimer
TipRanks·05/12 11:27
Stifel Nicolaus Sticks to Its Buy Rating for MBX Biosciences, Inc. (MBX)
Reuters·05/12 11:11
MBX BIOSCIENCES INC <MBX.O>: BARCLAYS RAISES TARGET PRICE TO $70 FROM $66
Reuters·05/12 10:46
MBX BIOSCIENCES INC <MBX.O>: STIFEL RAISES TARGET PRICE TO $56 FROM $50
TipRanks·05/12 10:07
MBX Biosciences price target raised to $70 from $66 at Barclays
TipRanks·05/12 09:47
MBX Biosciences price target raised to $86 from $76 at Citizens